Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06245187 · ClinicalTrials.gov registry record
Get With the Guidelines Atrial Fibrillation Registry
A clinical trial of Atrial Fibrillation and Atrial Flutter, sponsored by American Heart Association.
- Recruiting
- Registry status
- 17,198
- Enrollment target
- 1
- Study location
NCT06245187 is a study of Atrial Fibrillation and Atrial Flutter that is actively recruiting participants, run by American Heart Association. The registered enrollment target is 17,198 participants, above the 2,912-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (491% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06245187, a study of Atrial Fibrillation and Atrial Flutter, is actively recruiting participants, sponsored by American Heart Association.
- RECRUITING
- Registry status
- 17,198 participants
- Enrollment target
- 1
- Study location
Study Summary
Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.
Conditions Studied
Interventions
- OTHER GWTG Atrial Fibrillation program
Study Locations (1)
Texas
- Amy Bennett - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,198 participants |
| Start Date | 2013-01 |
| Est. Completion | 2040-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06245187
The ClinicalTrials.gov registry entry for NCT06245187 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 17,198 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,912-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (491% higher). The listed sponsor is American Heart Association, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which GWTG Atrial Fibrillation program is the first listed.
NCT06245187 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06245187 about?
NCT06245187 is a clinical study titled "Get With the Guidelines Atrial Fibrillation Registry". Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for contin...
What is the current status of trial NCT06245187?
This trial is currently recruiting. The enrollment target is 17,198 participants. The study started on 2013-01. Estimated completion is 2040-01.
What conditions does trial NCT06245187 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter.
What interventions are being tested in trial NCT06245187?
The interventions under investigation include: GWTG Atrial Fibrillation program (OTHER).
Who is sponsoring clinical trial NCT06245187?
This trial is sponsored by American Heart Association, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06245187 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.